Oncology Launch Account Executive – Ultra‑Rare Hematology

AbbVie Inc.; United States; Remote; USD 120,000 - 190,000; Full time

Benefits offered by this job

Paid time off

Medical insurance

401(k) plan

Job summary

AbbVie Inc. is seeking a Sr. Clinical Account Executive to drive the launch and promotion of a new oncology therapy in a defined Southern US territory.

The role focuses on building relationships with healthcare professionals and steering adoption of the new treatment within hematology. The position requires 5–7+ years in pharmaceutical or medical device sales, strong communication, and willingness to travel up to 75%.

Qualifications

• 5–7+ years of pharmaceutical and medical device sales experience.
• Strong written and verbal communication skills.
• Analytical skills with budget planning and management.
• Cross-functional collaboration and influence across matrix partners.
• Ability to travel up to 75% and drive a personal or company vehicle.

Responsibilities

• Establish and maintain relationships with key opinion leaders in the territory.
• Monitor and analyze territory-level sales data.
• Provide feedback to marketing on selling materials and strategies.
• Collaborate with cross-functional teams to support key accounts.
• Represent AbbVie in the ultra-rare hematology space with healthcare professionals and patient organizations.
• Attend local oncology society meetings and patient programs, including evenings or weekends.

Skills

Pharmaceutical sales

Healthcare industry knowledge

Relationship building

Communication

Strategic thinking

Education

Bachelor's degree or equivalent

Job description

AbbVie Inc. is seeking a Sr. Clinical Account Executive to drive the launch and promotion of a new oncology therapy in a defined Southern US territory.

The role focuses on building relationships with healthcare professionals and steering adoption of the new treatment within hematology. The position requires 5–7+ years in pharmaceutical or medical device sales, strong communication, and willingness to travel up to 75%.